Volume 29, Number 12—December 2023
Research
Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b Infections in Wild Terrestrial Mammals, United States, 2022
Table 1
Animal | Test | No. positive or present/no. tested or examined (%) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Nasal swab | OP swab | Nasal and OP swab | Tracheal swab | Brain | Heart | Lung | Liver | Lymphoid system | ||
Red fox |
PCR | 20/22 (90) | 15/18 (83) | 9/9 (100) | 5/7 (71) | 31/32 (96) | 7/8 (87) | 12/13 (92) | NA | NA |
Lesions | NA | NA | NA | NA | 38/38 (100) | 25/37 (68) | 35/38 (92) | 13/32 (41) | 18/32 (56) | |
IHC |
NA |
NA |
NA |
NA |
13/17 (76) |
3/5 (60) |
2/15 (13) |
1/3 (33) |
0/3 (0) |
|
Skunk |
PCR | NA | 1/1 (100) | NA | NA | 3/3 (100) | NA | 3/3 (100) | 2/2 (100)† | 2/2 (100)† |
Lesions | NA | NA | NA | NA | 3/5 (60) | 0/5 (0) | 5/5 (100) | 5/5 (100) | 5/5 (100) | |
IHC |
NA |
NA |
NA |
NA |
NA |
NA |
2/2 (100) |
5/5 (100) |
1/1 (100) |
|
Raccoon |
PCR | 1/1 (100) | 3/3 (100) | NA | NA | 1/1 (100) | NA | NA | NA | NA |
Lesions | NA | NA | NA | NA | 4/4 (100) | 1/4 (25) | 3/4 (75) | 1/4 (25) | 2/4 (50) | |
IHC |
NA |
NA |
NA |
NA |
1/1 (100) |
1/1 (100) |
1/1 (100) |
NA |
1/1 (100) |
|
Opossum |
PCR | NA | 2/2 (100) | 2/2 (100) | NA | 2/2 (100) | NA | NA | NA | NA |
Lesions | NA | NA | NA | NA | 1/2 (50) | 0/2 (0) | 0/2 (0) | 1/2 (50) | 0/2 (0) | |
IHC |
NA |
NA |
NA |
NA |
2/2 (100) |
NA |
1/2 (50) |
NA |
NA |
|
Bobcat |
PCR | 2/2 (100) | 2/2 (100) | NA | NA | 2/2 (100) | 1/2 (50) | 2/2 (100) | NA | NA |
Lesions | NA | NA | NA | NA | 2/2 (100) | 2/2 (100) | 1/2 (50) | 1/2 (50) | 2/2 (100) | |
IHC |
NA |
NA |
NA |
NA |
1/2 (50) |
NA |
0/2 (0) |
NA |
NA |
|
Coyote |
PCR | NA | NA | 1/1 (100) | 1/1 (100) | NA | NA | NA | NA | NA |
Lesions | NA | NA | NA | NA | 1/1 (100) | 1/1 (100) | 1/1 (100) | A | 0/1 (0) | |
IHC |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Gray fox |
PCR | NA | NA | 1/1 (100) | 0/1 (0) | 0/1 (0) | NA | NA | NA | NA |
Lesions | NA | NA | NA | NA | 0/1 (0) | 0/1 (0) | 0/1 (0) | 0/1 (0) | 0/1 (0) | |
IHC |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Fisher |
PCR | NA | 1/1 (100) | NA | NA | 1/1 (100) | NA | 1/1 (100) | 1/1 (100) | 1/1 (100) |
Lesions | NA | NA | NA | NA | 1/1 (100) | 0/1 (0) | 1/1 (100) | 1/1 (100) | 1/1 (100) | |
IHC |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
Total PCR results |
23/25 (92) |
24/27 (88) |
13/13 (100) |
6/9 (66) |
40/42 (95) |
8/10 (80) |
18/19 (94) |
3/3 (100)† |
3/3 (100)† |
|
Total lesion results |
NA |
NA |
NA |
NA |
50/54 (93) |
29/53 (55) |
46/54 (85) |
22/47 (47) |
28/48 (58) |
|
Total IHC results |
NA | NA | NA | NA | 17/22 (77) | 4/6 (67) | 6/22 (27) | 6/8 (78) | 2/5 (40) |
*Lesions were detected by using histopathologic analysis. A, major autolysis; IHC, immunohistochemical analysis; NA, not assessed; OP, oropharyngeal. †Sample includes pooled liver and spleen.
Page created: October 31, 2023
Page updated: November 18, 2023
Page reviewed: November 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.